Wordt geladen...
Treating Prostate Cancer by Antibody–Drug Conjugates
Prostate cancer is the most frequent malignancy in the worldwide male population; it is also one of the most common among all the leading cancer-related death causes. In the last two decades, the therapeutic scenario of metastatic castration-resistant prostate cancer has been enriched by the use of...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7913806/ https://ncbi.nlm.nih.gov/pubmed/33557050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041551 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|